Alexander (Alex) T. Nguyen is General Counsel in Residence at Wilson Sonsini Goodrich & Rosati. With more than 20 years of experience at the intersection of law, life sciences, and technology, Alex provides counsel to clients on business strategy, operations, and corporate governance.

Prior to joining the firm, Alex served as chief legal officer and head of operations at publicly traded UNITY Biotechnology, Inc. In this role, he led the legal, compliance, and operational functions, advising the CEO, board, and leadership team on business strategy, corporate governance, risk, and regulatory matters. He also negotiated and managed corporate transactions, term sheets, structured financings, licensing agreements, and strategic partnerships. As UNITY’s chief compliance officer, Alex also created and oversaw a compliance program based on HHS-OIG guidance, and handled equity administration, cybersecurity, and data governance. In addition, he drove SEC and FDA disclosures, managed contracts, and handled litigation for the company.

Alex previously held key roles for tech-driven subsidiaries of Roivant Sciences, including as general counsel at Alyvant, head of compliance at Roivant, and head of legal at Axovant Sciences. As GC of Alyvant, he led legal strategy for an AI/machine learning drug commercialization platform; negotiated licensing, co-promotion, commercial, and telemedicine agreements; and oversaw acquisitions due diligence, in addition to building a healthcare compliance program to enable scalable, tech-driven commercialization. As head of compliance for Roivant, Alex designed and implemented global compliance frameworks across over 90 entities covering healthcare, regulatory, data privacy and security, ethics, securities, and other key risk areas; supported IPO readiness and spin-outs; and managed subsidiary governance. Previously, as head of legal at Axovant, he oversaw corporate legal strategy and managed corporate governance, SEC filings, equity financings, venture debt, licensing agreements, litigation, internal investigations, regulatory compliance, risk management, and operations.

From 2007 to 2015, Alex worked as a federal prosecutor and Deputy Chief of the Cybercrime and IP Unit at the U.S. Attorney’s Office for the Eastern District of Virginia, focusing on FDA offenses, including illegal imports of adulterated and misbranded pharmaceuticals and prescription drug diversion. He investigated, prosecuted, and supervised high-profile matters involving cybercrime, IP theft, data breaches, corporate fraud, insider trading, ransomware, trade secret misappropriation, state-sponsored hacking, dark web activity, national security and terrorism matters, and other technology-related offenses.

Earlier in his career, Alex served as Assistant White House Counsel. In this role, he led high-impact legal and policy initiatives across Cabinet and federal agencies, including on data governance, technology policy, and Open Government efforts, and drove inter-agency implementation of technology, data, and process optimization priorities.

Alex was also a partner and chair of complex trial teams at a boutique firm specializing in data privacy, technology, and consumer protection litigation. He served as lead counsel on high-profile health and data privacy and cybersecurity class actions, including cases involving data breaches, biometrics, wiretapping, and unfair competition. Alex began his legal career as a litigation associate at Kirkland & Ellis.

Alex is admitted in the District of Columbia. He is not admitted in California and therefore not authorized to practice law in California.